Home » Topics » BioWorld Science

BioWorld Science
RSS

ADCON-L efficacy reported

April 5, 1996

Lilly's tachykinin antagonists for chronic pain

April 5, 1996

New 5alpha-reductase inhibitor from Merck & Co.

March 26, 1996

Tsumura Juntendo research into aldose reductase inhibitors

March 15, 1996

AI-401 slated to enter phase II

March 15, 1996

Sankyo reports drugs for diabetes

March 15, 1996

Antidiabetic drugs claimed by Tanabe Seiyaku

March 15, 1996

Lexipafant for pancreatitis

March 15, 1996

Zadaxin effective in HBV patients

March 15, 1996

Calixarene derivatives from University of Alabama

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...